OmniAb Inc

OmniAb Inc. is a company based in Oakland, California, specializing in the development of antibody-based therapeutics. With a team of 78 employees, OmniAb has generated $50 million in revenue. The company's core offering is the OmniAb discovery platform, a comprehensive suite of tools designed to accelerate the identification of novel antibodies for pharmaceutical applications. This platform grants industry partners access to a vast array of antibody repertoires, coupled with advanced high-throughput screening technologies. OmniAb differentiates itself through its proprietary technologies and its focus on providing a streamlined and efficient drug discovery process for its pharmaceutical partners. By leveraging its platform, partners can expedite the development of next-generation therapeutics with improved efficacy and safety profiles. For more information about OmniAb Inc. and its antibody discovery solutions, visit their website at omniab.com.